Consolidated Statements of Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands |
Common Stock
2022 Private Placement.
|
Common Stock
2021 Underwritten Public Offering
|
Common Stock
2021 Registered Direct Offering
|
Common Stock
Equity Distribution Agreement
|
Common Stock
LPC Purchase Agreement
|
Common Stock
Registered Direct Offering 2022
|
Common Stock |
Additional Paid-in Capital
2022 Private Placement.
|
Additional Paid-in Capital
2021 Underwritten Public Offering
2021 Pre-Funded Warrants
|
Additional Paid-in Capital
2021 Underwritten Public Offering
|
Additional Paid-in Capital
2021 Registered Direct Offering
|
Additional Paid-in Capital
Equity Distribution Agreement
|
Additional Paid-in Capital
LPC Purchase Agreement
|
Additional Paid-in Capital
Registered Direct Offering 2022
Class A Warrants
|
Additional Paid-in Capital
Registered Direct Offering 2022
|
Additional Paid-in Capital |
Accumulated Other Comprehensive Loss |
Accumulated Deficit |
2022 Private Placement. |
2021 Underwritten Public Offering
2021 Pre-Funded Warrants
|
2021 Underwritten Public Offering |
2021 Registered Direct Offering |
Equity Distribution Agreement |
LPC Purchase Agreement |
Registered Direct Offering 2022
Class A Warrants
|
Registered Direct Offering 2022 |
Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance at Jun. 30, 2021 | $ 8 | $ 194,229 | $ (168,138) | $ 26,099 | |||||||||||||||||||||||
Balance (in shares) at Jun. 30, 2021 | 8,352 | ||||||||||||||||||||||||||
Gross proceeds from issuance of common stock for cash | $ 6 | $ 1 | $ 1 | $ 18 | $ 39,950 | $ 4,999 | $ 1,518 | $ 1,172 | $ 64,372 | $ 39,956 | $ 5,000 | $ 1,519 | $ 1,172 | $ 64,390 | |||||||||||||
Gross proceeds from issuance of common stock for cash (in shares) | 6,147 | 769 | 138 | 116 | 18,026 | ||||||||||||||||||||||
Underwriting commissions, discounts and other equity offering costs | (4,596) | (4,596) | |||||||||||||||||||||||||
Share-based compensation | 3,685 | 3,685 | |||||||||||||||||||||||||
Reclassification of derivative liabilities to equity upon cure of authorized share deficiency | 35,025 | 35,025 | |||||||||||||||||||||||||
Issuance of commitment shares | $ 450 | $ 450 | |||||||||||||||||||||||||
Issuance of commitment shares (in shares) | 34 | ||||||||||||||||||||||||||
Fair value of warrants issued | $ 10,783 | $ 7,048 | $ 10,783 | $ 7,048 | |||||||||||||||||||||||
Net loss | (41,060) | (41,060) | |||||||||||||||||||||||||
Balance at Jun. 30, 2022 | $ 34 | 358,635 | (209,198) | 149,471 | |||||||||||||||||||||||
Balance (in shares) at Jun. 30, 2022 | 33,582 | ||||||||||||||||||||||||||
Gross proceeds from issuance of common stock for cash | $ 3 | $ 12,327 | $ 12,330 | ||||||||||||||||||||||||
Gross proceeds from issuance of common stock for cash (in shares) | 3,245 | ||||||||||||||||||||||||||
Underwriting commissions, discounts and other equity offering costs | (759) | (759) | |||||||||||||||||||||||||
Share-based compensation | 7,268 | 7,268 | |||||||||||||||||||||||||
Net change in accumulated other comprehensive loss | $ (351) | (351) | |||||||||||||||||||||||||
Net loss | (51,787) | (51,787) | |||||||||||||||||||||||||
Balance at Jun. 30, 2023 | $ 37 | $ 377,471 | $ (351) | $ (260,985) | $ 116,172 | ||||||||||||||||||||||
Balance (in shares) at Jun. 30, 2023 | 36,827 |
X | ||||||||||
- Definition The amount of decrease in additional paid in capital by reclassification of derivative liability for authorized share deficiency. No definition available.
|
X | ||||||||||
- Definition Number of new stock committed during the period. No definition available.
|
X | ||||||||||
- Definition Equity impact of the value of new stock committed during the period. No definition available.
|
X | ||||||||||
- Definition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of shares issued which are neither cancelled nor held in the treasury. No definition available.
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|